230 related articles for article (PubMed ID: 8996547)
21. [Bone turnover markers in the detection of bone metastases in primary lung cancer].
Kong QQ; Tu CQ; Dou QY; Wang JP; Sun TW
Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 May; 36(3):397-9. PubMed ID: 15931879
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic value of bone remodeling markers in the diagnosis of bone metastases in patients with breast cancer.
Pectasides D; Farmakis D; Nikolaou M; Kanakis I; Kostopoulou V; Papaconstantinou I; Karamanos NK; Economopoulos T; Raptis SA
J Pharm Biomed Anal; 2005 Feb; 37(1):171-6. PubMed ID: 15664758
[TBL] [Abstract][Full Text] [Related]
23. HER-2 expression is a prognostic factor in patients with metastatic breast cancer treated with a combination of high-dose cyclophosphamide, mitoxantrone, paclitaxel and autologous blood stem cell support.
Bewick M; Conlon M; Gerard S; Lee H; Parissenti AM; Zhang L; Glück S; Lafrenie RM
Bone Marrow Transplant; 2001 Apr; 27(8):847-53. PubMed ID: 11477443
[TBL] [Abstract][Full Text] [Related]
24. Leukocyte alkaline phosphatase as a probable predictor of the metastatic state in breast and colon cancer patients.
Walach N; Gur Y
Oncology; 1995; 52(1):12-8. PubMed ID: 7800336
[TBL] [Abstract][Full Text] [Related]
25. Value of serum-5-nucleotidase, alkaline phosphatase and gamma-glutamyl transferase for prediction of liver metastases preoperatively in colorectal cancer.
Jönsson PE; Bengtsson G; Carlsson G; Jonson G; Tryding N
Acta Chir Scand; 1984; 150(5):419-23. PubMed ID: 6148827
[TBL] [Abstract][Full Text] [Related]
26. [Role of biochemical indices as metastatic markers in patients with prostatic cancer invading skeleton].
Liubimova NV; Trapeznikova MF; Robins SP; Ognerubov SA; Kushlinskiĭ NE
Urologiia; 2000; (4):15-9. PubMed ID: 11186686
[TBL] [Abstract][Full Text] [Related]
27. Differential expression of carcinoembryonic antigen (CEA) splice variants in whole blood of colon cancer patients and healthy volunteers: implication for the detection of circulating colon cancer cells.
Hampton R; Walker M; Marshall J; Juhl H
Oncogene; 2002 Nov; 21(51):7817-23. PubMed ID: 12420218
[TBL] [Abstract][Full Text] [Related]
28. Leukocyte alkaline phosphatase, CA15-3, CA125, and CEA in cancer patients.
Walach N; Gur Y
Tumori; 1998; 84(3):360-3. PubMed ID: 9678617
[TBL] [Abstract][Full Text] [Related]
29. The amino-terminal propeptide (PINP) of type I collagen is a clinically valid indicator of bone turnover and extent of metastatic spread in osseous metastatic breast cancer.
Pollmann D; Siepmann S; Geppert R; Wernecke KD; Possinger K; Lüftner D
Anticancer Res; 2007; 27(4A):1853-62. PubMed ID: 17649784
[TBL] [Abstract][Full Text] [Related]
30. [Elevation of serum Ca 15-3 antigen: an early indicator of distant metastasis from breast cancer. Retrospective analysis of 733 cases].
Wojtacki J; Kruszewski WJ; Sliwińska M; Kruszewska E; Hajdukiewicz W; Sliwiński W; Rolka-Stempniewicz G; Góralczyk M; Leśniewski-Kmak K
Przegl Lek; 2001; 58(6):498-503. PubMed ID: 11816740
[TBL] [Abstract][Full Text] [Related]
31. Abnormal bone remodeling process is due to an imbalance in the receptor activator of nuclear factor-kappaB ligand (RANKL)/osteoprotegerin (OPG) axis in patients with solid tumors metastatic to the skeleton.
Mountzios G; Dimopoulos MA; Bamias A; Papadopoulos G; Kastritis E; Syrigos K; Pavlakis G; Terpos E
Acta Oncol; 2007; 46(2):221-9. PubMed ID: 17453373
[TBL] [Abstract][Full Text] [Related]
32. [Serum alkaline phosphatase flare in prostate cancer accompanied by bone metastases and treated with hormonal therapy. TEKK Study Group].
Taue R; Kanayama H; Kagawa S
Hinyokika Kiyo; 1999 Oct; 45(10):681-5. PubMed ID: 10586358
[TBL] [Abstract][Full Text] [Related]
33. [Serum alkaline phosphatase levels in tumor patients].
Abasov IT
Vopr Onkol; 1967; 13(2):45-7. PubMed ID: 5628492
[No Abstract] [Full Text] [Related]
34. Alkaline phosphatase isoenzymes for the diagnosis of metastatic tumors and lymphomas of liver and bone.
Yorio MA; Sembaj A; Sanz E; Carriazo C; Moreno Barral J
Medicina (B Aires); 2000; 60(3):311-5. PubMed ID: 11050806
[TBL] [Abstract][Full Text] [Related]
35. Importance of serum prolactin determination in metastatic breast cancer patients.
Mujagić Z; Mujagić H
Croat Med J; 2004 Apr; 45(2):176-80. PubMed ID: 15103755
[TBL] [Abstract][Full Text] [Related]
36. Sequential estimation of alkaline phosphatase isoenzymes (API) in breast cancer patients.
Horner GU; Caffier HO
Cancer Detect Prev; 1981; 4(1-4):205-9. PubMed ID: 7349778
[TBL] [Abstract][Full Text] [Related]
37. [Effects of chemotherapy on circulating angiogenic factor levels in patients with breast cancer].
Tang JH; Zhao JH; Gong JP; Qin JW; Pan LQ; Xu ZY
Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):210-4. PubMed ID: 17649639
[TBL] [Abstract][Full Text] [Related]
38. The circadian rhythm of biochemical markers of bone resorption is normally synchronized in breast cancer patients with bone lytic metastases independently of tumor load.
Generali D; Berruti A; Tampellini M; Dovio A; Tedoldi S; Bonardi S; Tucci M; Allevi G; Aguggini S; Milani M; Bottini A; Dogliotti L; Angeli A
Bone; 2007 Jan; 40(1):182-8. PubMed ID: 16935041
[TBL] [Abstract][Full Text] [Related]
39. Higher prostate-specific antigen levels predict improved survival in patients with hormone-refractory prostate cancer who have skeletal metastases and normal serum alkaline phosphatase.
Xie W; Nakabayashi M; Regan MM; Oh WK
Cancer; 2007 Dec; 110(12):2709-15. PubMed ID: 17960608
[TBL] [Abstract][Full Text] [Related]
40. [Leukocyte alkaline phosphatase in breast cancer].
Wallach N; Kaufman S; Zigum L; Horn Y
Harefuah; 1984 Jan; 106(1):12-4. PubMed ID: 6714823
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
